Recent CRVS News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2024 09:40:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2024 09:39:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2024 12:30:14 PM
- Corvus Pharmaceuticals Announces Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis • GlobeNewswire Inc. • 12/18/2024 12:30:00 PM
- Corvus Pharmaceuticals to Announce Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on December 18, 2024 • GlobeNewswire Inc. • 12/17/2024 09:01:00 PM
- Corvus Pharmaceuticals Announces Publication of Biochemistry and Preclinical Data Demonstrating Potential of ITK Inhibition with Soquelitinib as a Novel Approach to Modulate Tumor Immunity • GlobeNewswire Inc. • 12/04/2024 09:05:57 PM
- Corvus Pharmaceuticals Announces New Preclinical Data Highlighting Potential of Soquelitinib to Treat Systemic Sclerosis • GlobeNewswire Inc. • 11/14/2024 03:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:03:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 09:02:10 PM
- Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 11/12/2024 09:01:00 PM
- Corvus Pharmaceuticals Announces New Data Highlighting Potential of Ciforadenant to Overcome Immunotherapy Resistance in Metastatic Castration Resistant Prostate Cancer • GlobeNewswire Inc. • 11/09/2024 06:40:00 PM
- Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2024 Financial Results on November 12, 2024 • GlobeNewswire Inc. • 11/05/2024 09:02:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2024 08:11:13 PM
- Corvus Pharmaceuticals Initiates Registrational Phase 3 Clinical Trial of Soquelitinib for Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma • GlobeNewswire Inc. • 09/10/2024 12:30:00 PM
- Corvus Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/03/2024 08:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/16/2024 04:15:18 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/06/2024 09:31:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:02:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:01:13 PM
- Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/06/2024 08:01:00 PM
- Corvus Pharmaceuticals Granted FDA Fast Track Designation for Soquelitinib for Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) • GlobeNewswire Inc. • 08/01/2024 12:30:00 PM
- Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2024 Financial Results on August 6, 2024 • GlobeNewswire Inc. • 07/31/2024 12:30:00 PM
- Publication of Preclinical Data in Science Signaling Demonstrated the Potential of ITK Inhibition with Soquelitinib as a Novel Approach to Treatment of Inflammatory Diseases • GlobeNewswire Inc. • 07/25/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 08:44:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:15:20 PM
Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • HZLIF • Dec 20, 2024 9:00 AM
North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM
Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM
$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM
UAV Corp's (UMAV), Skyborne Technology to Build "SKY" Hangar at Its Costin Airport Scheduled for Groundbreaking Ceremony Winter 2025 • UMAV • Dec 20, 2024 8:30 AM
UAV Corp. (UMAV) Reduces Authorized Shares by 1.2 Billion, Demonstrating Commitment to Shareholders; New Authorized Share Count Approved at 800 Million • UMAV • Dec 17, 2024 12:00 PM